Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- ETH Zurich
- ETH Zürich
- Empa
- University of Basel
- University of Zurich
- Academic Europe
- Swiss Federal Institute for Forest, Snow and Landscape Research WSL
- Zürcher Hochschule für Angewandte Wissenschaft ZHAW
- EPFL
- Ecole Polytechnique Federale de Lausanne - EPFL
- Nature Careers
- Paul Scherrer Institut Villigen
- University of Applied Sciences Northwestern Switzerland
- University of Bern
- 4 more »
- « less
-
Field
-
of all our staff and students are respected. Visit our Equal Opportunities and Diversity website to find out how we ensure a fair and open environment that allows everyone to grow and flourish
-
Diversity website to find out how we ensure a fair and open environment that allows everyone to grow and flourish. Sustainability is a core value for us – we are consistently working towards a climate-neutral
-
-, immunoglobulin downstream signaling involved in an inflammatory and metabolic network. Functional immune cell / phenotypic / response output assays and biomarker detection /identification in vitro and in vivo
-
30,000 people from more than 120 countries find our university to be a place that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging
-
environment in which the rights and dignity of all our staff and students are respected. Visit our Equal Opportunities and Diversity website to find out how we ensure a fair and open environment that allows
-
nurture a working and learning environment in which the rights and dignity of all our staff and students are respected. Visit our Equal Opportunities and Diversity website to find out how we ensure a fair
-
aims to determine the molecular basis of disease mechanism in order to find novel targets for treatment. Job description Management of daily functions, organization and smooth running of the laboratory
-
mechanisms underlying bacterial infections and the emergence of antimicrobial resistance, and (2) evaluate novel treatment strategies. A key objective is to optimize the platform for translational applications
-
to shape the direction of the project after the initial objectives are met. The project is funded through an ETH grant and will be supervised by Dr. Juliana Laszakovits in the group of Prof. Kristopher
-
platform . To receive the confirmation letter in time, please start the approval process no later than 15 December 2025. On AVA you will also find help with budgeting your project. Please contact